Received: 10 June 2022
Accepted: 3 August 2023
First Online: 29 August 2023
: We obtained the consent of our patient’s parents to participate in our case report. It should be noted that the results of the genetic study were available after the patient’s demise, and we did not intend to report the case before that. This being said, our research did not have any influence on the course of the treatment. The study adhered to the tenets of Helsinki Declaration, and the ethical committee of our institution, Tehran University of Medical Sciences (TUMS). We used no experimental protocol, and the article was written after the patient’s demise.
: Written informed consent was obtained from the patient’s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: There are no competing interests to declare.